1. K-State home
  2. »Division of Communications and Marketing
  3. »K-State Today
  4. »Mylan EpiPen Auto-Injector recall

K-State Today

April 4, 2017



Mylan EpiPen Auto-Injector recall

By Julie Gibbs

Lafene Health Center encourages students, faculty and staff to check the FDA's recent nationwide voluntary recall of 13 lots of EpiPen and EpiPen Jr because of a potentially defective part.

The defective part may result in the devices' failure to activate and the medication may not be delivered as expected when injected. The recalled product was manufactured by Meridian Medical Technologies and distributed by Mylan Specialty.

View a PDF document of the 13 recalled lots, distributed between Dec. 17, 2015 and July 1, 2016.

While the number of reported failures is small, EpiPen products that potentially contain a defective part could fail to activate when needed if a person is experiencing a severe allergic reaction. Consumers should keep and use their current EpiPens if needed until they get a replacement.

Consumers are encouraged to contact Mylan at 800-796-9526 or customer.service@mylan.com with any questions.

In this issue

From the administration
News and research
Events
Kudos, publications and presentations
Technology
Safety
University life